CD34 and FSHR Expression to Differentiate Multiple Subtypes of Benign and Malignant Renal Neoplasms

BackgroundCurrently, no markers accurately differentiate benign from malignant renal masses. CD34 and FSHR are transmembrane proteins involved in neo-angiogenetic pathways and are differently expressed in several normal and cancerous tissues. However, little evidence exists on their distribution in...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Giancarlo Marra, Didier Meseure, Marine Lefèvre, Andre Nicolas, Laetitia Lesage, Nicolae Ghinea, Marco Moschini, Caio Pasquali, Petr Macek, Claudia Filippini, Paolo Gontero, Rafael Sanchez-Salas, Xavier Cathelineau
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2022-05-01
Seri Bilgileri:	Société Internationale d’Urologie Journal
Konular:	kidney cancer cd34 fshr tumor markers
Online Erişim:	https://siuj.org/index.php/siuj/article/view/183/115
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

CD34 and FSHR Expression to Differentiate Multiple Subtypes of Benign and Malignant Renal Neoplasms

Benzer Materyaller